An L- and T-type calcium channel blocker
Related Products
Labeled Version(s)
30768Manidipine-d4
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Manidipine

Item No. 23614

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid, 3-[2-[4-(diphenylmethyl)-1-piperazinyl]ethyl] 5-methyl ester
CAS Number
89226-50-6
Synonyms
  • CV-4093
  • Franidipine
  • (±)-Manidipine
Molecular Formula
C35H38N4O6
Formula Weight
610.7
Purity
≥98%
Formulation (Request formulation change)
A crystalline solid
Solubility(Learn about Variance in Solubility)
DMF: 30 mg/mlDMSO: 30 mg/mlDMSO:PBS (pH 7.2) (1:3): 0.25 mg/mlEthanol: 15 mg/ml
λmax
230, 348 nm
SMILES
O=C(OC)C1=C(C)NC(C)=C(C(OCCN2CCN(C(C3=CC=CC=C3)C4=CC=CC=C4)CC2)=O)C1C5=CC=CC([N+]([O-])=O)=C5
InChi Code
InChI=1S/C35H38N4O6/c1-24-30(34(40)44-3)32(28-15-10-16-29(23-28)39(42)43)31(25(2)36-24)35(41)45-22-21-37-17-19-38(20-18-37)33(26-11-6-4-7-12-26)27-13-8-5-9-14-27/h4-16,23,32-33,36H,17-22H2,1-3H3
InChi Key
ANEBWFXPVPTEET-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    10 mg

    $121

    Add

    25 mg

    $227

    Add

    50 mg

    $388

    Add
    Product Description

    Manidipine is a dihydropyridine L- and T-type calcium channel blocker.1,2,3 It blocks recombinant rabbit L-type (α1Cα2/δβ1a) and human T-type (α1H) calcium channels expressed in Xenopus oocytes and native L-type channels in dissociated guinea pig cardiac ventricular cells (IC50 = 2.6 nM). Manidipine inhibits intracellular calcium increases induced by endothelin-1 (ET-1; Item No. 24127) in A7r5 rat vascular smooth muscle cells (ED50 = 1 nM) and potassium-induced contraction of isolated dog femoral and portal veins (IC50s = 24 and 2.1 nM, respectively).4,5 In vivo, it lowers blood pressure in spontaneously hypertensive rats (SHRs) when administered at a dose of 10 mg/kg and inhibits left ventricular hypertrophy in rats induced by isoproterenol (Item No. 15592) when administered at a dose of 3 mg/kg.6,7 Formulations containing manidipine have been used in the treatment of hypertension.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Furukawa, T., Nukada, T., Miura, R., et al. Differential blocking action of dihydropyridine Ca2+ antagonists on a T-type Ca2+ channel (α1G) expressed in Xenopus oocytes. J. Cardiovasc. Pharmacol. 45(3), 241-246 (2005).

    2. Furukawa, T., Nukada, T., Namiki, Y., et al. Five different profiles of dihydropyridines in blocking T-type Ca2+ channel subtypes (Cav3.1 (α1G), Cav3.2 (α1H), and Cav3.3 (α1I)) expressed in Xenopus oocytes. Eur. J. Pharmacol. 613(1-3), 100-107 (2009).

    3. Tohse, N., Takeda, Y., and Kanno, M. Voltage-dependent modulation of L-type Ca2+ current by manidipine in guinea-pig heart cells. Eur. J. Pharmacol. 249(2), 231-233 (1993).

    4. Huang, S., Simonson, M.S., and Dunn, M.J. Manidipine inhibits endothelin-1-induced [Ca2+]i signaling but potentiates endothelin’s effect on c-fos and c-jun induction in vascular smooth muscle and glomerular mesangial cells. Am. Heart J. 125(2 Pt 2), 589-597 (1993).

    5. Shibouta, Y., Kitayoshi, T., Kitoh, G., et al. Calcium channel blocking action of franidipine hydrochloride (CV-4093·2HCl) in vitro and in vivo. Jpn. J. Pharmacol. 48(4), 463-472 (1988).

    6. Meguro, K., Aizawa, M., Sohda, T., et al. New 1,4-dihydropyridine derivatives with potent and long-lasting hypotensive effect. Chem. Pharm. Bull. (Tokyo) 33(9), 3787-3797 (1985).

    7. Yoshiyama, M., Takeuchi, K., Kim, S., et al. Effect of manidipine hydrochloride, a calcium antagonist, on isoproterenol-induced left ventricular hypertrophy. Jpn. Circ. J. 62(1), 47-52 (1998).